USPTO serial 79264358
G GERMAN INTERNATIONAL CLINICS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Feb 9, 2021
- Examiner
- PARKS, KIMBERLY L
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with G GERMAN INTERNATIONAL CLINICS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $748*
Plus Government fees of $650
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Margaret C. McHugh
Margaret C. McHugh KILPATRICK TOWNSEND & STOCKTON LLPTWO EMBARCADERO CENTER SUITE 1900SAN FRANCISCO, CA 94111UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 010 | Medical and veterinary apparatus and instruments, namely, blood filters, blood purification filters, filters for removing toxins, pesticides, parasites, drugs, poisons, heavy metals, bacteria, viruses, immunopathogenic agents, bilirubin, and beta 2 microglobulin, drug delivery filters sold empty, fluid filters, peristaltic filters, artificial membrane filters, centrifugal pumps for blood preparation, blood transport, oxygen transport, adsorbers for blood purification, toxin, pesticide, parasite, drug, poison, heavy metal, bacteria, virus, immunopathogenic agent, bilirubin, and beta 2 microglobulin, heat exchangers, oxygenators, devices for ozone production in the nature of ozone generators, ozone devices for the treatment of blood, ozone devices for the killing and removal of bacteria, viruses, and parasites, tube systems comprised of tubes for passing blood and fluids, hemoperfusion devices, blood purification devices, devices for inducing hyperthermia, devices for thermotherapy, blood perfusion devices, perfusion devices for the treatment of blood, perfusion cutlery for surgery; medical and veterinary apparatus and instruments, namely, diagnostic and therapeutic equipment for use in the pharmaceutical, medical and veterinary fields, namely, equipment for blood gas analysis, devices for measuring blood coagulation, devices for measuring oxygen saturation, devices for measuring body temperature, hemoperfusion devices for the treatment of blood, clinical laboratory analyzers for blood and blood component analysis, chemistry analyzers for blood and blood component analysis, automated sample handling equipment for testing purposes, immunohematology analyzer for blood and blood component analysis, apparatus for blood screening, blood typing, and detection of assays associated with blood screening and blood typing used in the transfusion medicine market; Medical equipment for use in treating hyperthermia, and for thermotherapy, chemotherapy, electrochemical therapy, or radiotherapy, namely, heat exchangers, devices for inducing hyperthermia, devices for thermotherapy, infusion equipment sold empty for drug delivery, pain therapy, blood purification, and blood perfusion, radiotherapy equipment, and medical apparatus for treating diseases in the nature of cancer, borreliose, chronical diseases, and regenerative diseases, namely, filters, pumps, adsorbers, heat exchangers, oxygenators, ozone devices, tube systems, hemoperfusion devices, blood purification devices, devices for inducing hyperthermia, devices for thermotherapy, perfusion devices, and perfusion cutlery; medical apparatus for treating hyperthermia or carrying out apheresis, namely, heat exchangers, devices for inducing hyperthermia, devices for thermotherapy, and apheresis devices or units for filtering, purification, detoxification and separation of blood | ACTIVE | — |
| 044 | Hygienic care for human beings or animals | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Gerhard Siebenhüner
- Other trademarks owned by Gerhard Siebenhüner
- Other trademarks owned by Gerhard Siebenhüner
- Other trademarks in Class 010
- Other trademarks in Class 044
- Similar marks named G GERMAN INTERNATIONAL CLINICS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 9, 2026 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| May 30, 2021 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| May 11, 2021 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| May 11, 2021 | FIMP | FINAL DISPOSITION PROCESSED | — |
| May 9, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Feb 9, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 23, 2021 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Jan 6, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jan 6, 2021 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Dec 19, 2020 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Nov 27, 2020 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Nov 24, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 24, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 4, 2020 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Nov 4, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 20, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 20, 2020 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Oct 20, 2020 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Oct 20, 2020 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Oct 20, 2020 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Oct 7, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 6, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 6, 2020 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Aug 4, 2020 | GNS1 | NOTIFICATION OF SUBSEQUENT FINAL EMAILED | — |
| Aug 4, 2020 | GNCF | CONTINUATION OF FINAL REFUSAL E-MAILED | — |
| Aug 4, 2020 | CNCF | ACTION CONTINUING A FINAL - COMPLETED | — |
| Jul 8, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 7, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 7, 2020 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Apr 13, 2020 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Apr 13, 2020 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 13, 2020 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Mar 20, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 19, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 19, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 26, 2019 | RFNT | REFUSAL PROCESSED BY IB | — |
| Oct 5, 2019 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Oct 5, 2019 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 20, 2019 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 19, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 4, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 13, 2019 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 9, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 1, 2019 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |